CSI Market
Sign In | Register

Novavax inc (NVAX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access NVAX Annual Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Novavax inc's cash-generating activities.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-62.88
Depreciation & amortization6.12
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-55.66
Impairment of Long-Lived Assets Held-for-use2.40
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories2.14
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation15.81
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Lease And Rental Expense-
Depreciation And Amortization Otherthan Right Of Use Asset-
Provision For Excess And Obsolete Inventory-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Other Receivables0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-97.17
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-95.12
Other Working Capital0.00
Other Noncash Income (Expense)7.62
Other net0.00
Payments for (Proceeds from) Other Operating Activities171.51
Discontinued operations0.00
Net Cash flow from Operating Activities-105.23
Investing Activities
Capital Expenditures-1.86
Sale of Capital Items39.75
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities264.46
Payments to Acquire Available-for-sale Securities, Debt-295.82
Real Estate Investments0.00
Proceeds From Sale Of Assets-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities6.54
Financing Activities
Short-term debt Net46.41
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-7.54
Payment For Capped Call Transactions And Expenses-
Treasury Stock Related To Tax Withholding For Share Based Compensation Value-
Finance Lease Principal Payments-0.58
Net Proceeds From The Exercise Of Stock Based Awards-8.16
Proceeds From Exercise Of Stock Based Awards Net Of Tax Withholding-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities38.88
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-67.34
Total Cash Flow-60.01
4 historic quarters locked

Sign in to unlock the full Novavax inc cash flow history.

Sign In Create Free Account

About Novavax Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001000694-26-000018

Figures are derived from filed reports and may be restated. Historical data is subject to revision.